Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Levcromakalim

🥰Excellent
Catalog No. TQ0150Cas No. 94535-50-9
Alias BRL 38227, (-)-Cromakalim

Levcromakalim (BRL 38227) is an activator of the ATP-sensitive K+ channel.

Levcromakalim

Levcromakalim

🥰Excellent
Purity: 99.74%
Catalog No. TQ0150Alias BRL 38227, (-)-CromakalimCas No. 94535-50-9
Levcromakalim (BRL 38227) is an activator of the ATP-sensitive K+ channel.
Pack SizePriceAvailabilityQuantity
1 mg$48In Stock
2 mg$71In Stock
5 mg$101In Stock
10 mg$153In Stock
25 mg$353In Stock
50 mg$525In Stock
100 mg$759In Stock
1 mL x 10 mM (in DMSO)$112In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Levcromakalim"

Select Batch
Purity:99.74%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Levcromakalim (BRL 38227) is an activator of the ATP-sensitive K+ channel.
In vitro
Levcromakalim inhibits spontaneous contractions completely in a glibenclamide-sensitive manner. LevCromakalim (5 μM) inhibits spontaneous contractions, which are recovered by glibenclamide. Levcromakalim (1, 5 and 10 μM) inhibits phasic contractions to 34±21.1%, 20.1±20.0% and 0% of the control. Glibenclamide reverses the inhibition of spontaneous isometric contractions caused by LevCromakalim (5 μM) to 84±1.5% of the control. Levcromakalim (20 and 100 μM) also inhibits oxytocin (OXT) (10 nM)-induced phasic contractions to 34±21.4% and 14±12.6% of the control [2]. LevCromakalim induces dose-dependent relaxation in both the young and old mesenteric artery (MAs); there is no difference in relaxation with age. However, the relaxation is markedly reduced in response to the high-salt (HS) diet in the old MAs (P<0.05). Maximum dilations to Levcromakalim (10-4 M) are 97 ± 3% in the young MAs versus 98 ± 1% in the young salt arteries, while dilations are 99±0.7% in the old MAs when compared with 85 ± 5% in the old salt arteries (P<0.05) [3].
AliasBRL 38227, (-)-Cromakalim
Chemical Properties
Molecular Weight286.33
FormulaC16H18N2O3
Cas No.94535-50-9
SmilesCC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N1CCCC1=O)C#N
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: Insoluble
DMSO: 50 mg/mL (174.62 mM )
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4925 mL17.4624 mL34.9247 mL174.6237 mL
5 mM0.6985 mL3.4925 mL6.9849 mL34.9247 mL
10 mM0.3492 mL1.7462 mL3.4925 mL17.4624 mL
20 mM0.1746 mL0.8731 mL1.7462 mL8.7312 mL
50 mM0.0698 mL0.3492 mL0.6985 mL3.4925 mL
100 mM0.0349 mL0.1746 mL0.3492 mL1.7462 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Levcromakalim | purchase Levcromakalim | Levcromakalim cost | order Levcromakalim | Levcromakalim chemical structure | Levcromakalim in vitro | Levcromakalim formula | Levcromakalim molecular weight